Examining the association between maternal analgesic use during pregnancy and risk of psychotic symptoms during adolescence

Schizophrenia Research

Volumn 126, Issue 1-3, 2011, Pages 220-225

  Gunawardana, Lihini ^a   Zammit, Stanley ^a,b   Lewis, Glyn ^b   Gunnell, David ^b   Hollis, Chris ^c   Wolke, Dieter ^d   Harrison, Glynn ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

ALSPAC; Aspirin; Pregnancy; Prostaglandins; Psychotic symptoms

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; PARACETAMOL;

ARTICLE; CHILD; CONTROLLED STUDY; DELUSION; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; FEMALE; HALLUCINATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; RISK ASSESSMENT; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW;

ACETAMINOPHEN; ANALGESICS; ASPIRIN; CHILD; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DELUSIONS; FEMALE; HALLUCINATIONS; HUMANS; LOGISTIC MODELS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTIC DISORDERS; QUESTIONNAIRES; RISK FACTORS; SELF REPORT;

EID: 79952009520     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.10.021     Document Type: Article

References (32)

1. Barr C.E., Mednick S.A., Munk-Jorgensen P. Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study. Arch. Gen. Psychiatry 1990, 47:869-874.
2. Berger G.E., Wood S.J., Pantelis C., Velakoulis D., Wellard R.M., McGorry P.D. Implications of lipid biology for the pathogenesis of schizophrenia. Aust N Z J Psychiatry 2002, 36:355-366.
3. Boksa P. Maternal infection during pregnancy and schizophrenia. J. Psychiatry Neurosci. 2008, 33:183-185.
4. Brown A.S., Cohen P., Greenwald S., Susser E. Nonaffective psychosis after prenatal exposure to rubella. Am. J. Psychiatry 2000, 157:438-443.
5. Brown A.S., Susser E.S. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr. Bull. 2008, 34:1054-1063.
6. Buretic-Tomljanovic A., Giacometti J., Nadalin S., Rubesa G., Vulin M., Tomljanovic D. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia. Psychiatr. Danub. 2008, 20:372-383.
7. Byrne M., Agerbo E., Bennedsen B., Eaton W.W., Mortensen P.B. Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study. Schizophr. Res. 2007, 97:51-59.
8. Cannon M., Jones P.B., Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry 2002, 159:1080-1092.
9. Edwards M.J. Hyperthermia in utero due to maternal influenza is an environmental risk factor for schizophrenia. Congenit Anom Kyoto 2007, 47:84-89.
10. Dalman C., Allebeck P., Gunnell D., Harrison G., Kristensson K., Lewis G., Lofving S., Rasmussen F., Wicks S., Karlsson H. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am. J. Psychiatry 2008, 165:59-65.
11. Fatemi S.H., Folsom T.D. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr. Bull. 2009, 35:528-548.
12. Fruntes V., Limosin F. Schizophrenia and viral infection during neurodevelopment: a pathogenesis model?. Med. Sci. Monit. 2008, 14:RA71-RA77.
13. Golding J., Pembrey M., Jones R. ALSPAC-the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatr. Perinat. Epidemiol. 2001, 15:74-87.
14. Hillbrand M., Spitz R.T., VandenBos G.R. Investigating the role of lipids in mood, aggression, and schizophrenia. Psychiatr. Serv. 1997, 48(875-876):882.
15. Horwood J., Thomas K., Duffy L., Gunnell D., Hollis C., Lewis G., Thompson A., Wolke D., Zammit S., Harrison G. Frequency of psychosis-like symptoms in a non-clinical population of 12year olds: results from the ALSPAC birth cohort. Schizophr. Res. 2008, 98:77-78.
16. Kelleher I., Harley M., Lynch F., Arseneault L., Fitzpatrick C., Cannon M. Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample. Br. J. Psychiatry 2008, 193:378-382.
17. Leonhardt Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation. Pediatrics 2003, 3:e77-e81.
18. Limosin F., Rouillon F., Payan C., Cohen J.-M. Prenatal exposure to influenza as a risk factor for adult schizophrenia. Acta Psychiatr. Scand. 2003, 107:331-335.
19. Mortensen P.B., Pedersen M.G., Pedersen C.B. Psychiatric family history and schizophrenia risk in Denmark: which mental disorders are relevant?. Psychol. Med. 2010, 40:201-210.
20. Poulton R., Caspi A., Moffitt T.E., Cannon M., Murray R., Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch. Gen. Psychiatry 2000, 57:1053-1058.
21. Reddy R.D., Yao J.K. Environmental factors and membrane polyunsaturated fatty acids in schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:385-391.
22. Shaffer D., Fisher P., Lucas C.P., Dulcan M.K., Schwab-Stone M.E. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J. Am. Acad. Child Adolesc. Psychiatry 2000, 39:28-38.
23. Skosnik P.D., Yao J.K. From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:367-384.
24. Sorensen H.J., Mortensen E.L., Reinisch J.M., Mednick S.A. Association between prenatal exposure to analgesics and risk of schizophrenia. Br. J. Psychiatry 2004, 185:366-371.
25. Sorensen H.J., Mortensen E.L., Reinisch J.M., Mednick S.A. Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophr. Bull. 2009, 35:631-637.
26. Spauwen, J., Krabbendam, L., Lieb, R., Wittchen, H.U., & van Os, J., 2004. Early maternal stress and health behaviours and offspring expression of psychosis in adolescence. Acta. Psychiatr. Scand. 110, 356-364.
27. van Os J., Linscott R.J., Myin-Germeys I., Delespaul P., Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol. Med. 2009, 39:179-195.
28. WHO Schedules for Clinical Assessment in Neuropsychiatry 1994, American Psychiatric Research, Washington, DC.
29. Wicks S., Hjern A., Gunnell D., Lewis G., Dalman C. Social adversity in childhood and the risk of developing psychosis: a national cohort study. Am. J. Psychiatry 2005, 162:1652-1657.
30. Zammit S., Allebeck P., Dalman C., Lundberg I., Hemmingson T., Owen M.J., Lewis G. Paternal age and risk for schizophrenia. Br. J. Psychiatry 2003, 183:405-408.
31. Zammit S., Odd D., Horwood J., Thompson A., Thomas K., Menezes P., Gunnell D., Hollis C., Wolke D., Lewis G., Harrison G. Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12years in the ALSPAC birth cohort. Psychol. Med. 2009, 39:1457-1467.
32. Zammit S., Thomas K., Thompson A., Horwood J., Menezes P., Gunnell D., Hollis C., Wolke D., Lewis G., Harrison G. Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring. Br. J. Psychiatry 2009, 195:294-300.